Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113289951> ?p ?o ?g. }
Showing items 1 to 92 of
92
with 100 items per page.
- W2113289951 endingPage "9294" @default.
- W2113289951 startingPage "9290" @default.
- W2113289951 abstract "To assess response, overall survival, and relapse-free survival of patients with good-risk metastatic germ cell tumor (GCT) by International Germ Cell Consensus Classification Group (IGCCCG) criteria treated with four cycles of etoposide and cisplatin (EP).Two hundred eighty-nine patients with IGCCCG good-risk GCT were treated with four cycles of EP. EP consisted of four cycles of etoposide 100 mg/m2 and cisplatin 20 mg/m2 on days 1 to 5 every 21 days.Two hundred eighty-two of 289 patients (98%) achieved a complete response; 269 (93%) responded to chemotherapy alone and 13 (5%) responded to chemotherapy plus surgical resection of viable disease (GCT other than mature teratoma). Seventeen (6%) experienced relapse, and nine (3%) died as a result of disease at a median follow-up of 7.7 years (range, 0.4 to 21.1 years). Sixty-two of 204 patients (30%) with nonseminoma had findings of teratoma or viable GCT at postchemotherapy surgery.Four cycles of EP is a highly effective therapy for patients with good-risk GCT, with a high cure rate, low relapse rate, and little evidence of late relapse. Postchemotherapy surgery resection of residual disease remains an important aspect of treatment for these patients. Four cycles of EP is acceptable as a standard regimen for the treatment of good-risk metastatic GCT, and serves as an alternative to three cycles of bleomycin and etoposide before cisplatin." @default.
- W2113289951 created "2016-06-24" @default.
- W2113289951 creator A5005184400 @default.
- W2113289951 creator A5008235255 @default.
- W2113289951 creator A5021164812 @default.
- W2113289951 creator A5022528773 @default.
- W2113289951 creator A5054077386 @default.
- W2113289951 creator A5059063118 @default.
- W2113289951 creator A5064884168 @default.
- W2113289951 date "2005-12-20" @default.
- W2113289951 modified "2023-10-17" @default.
- W2113289951 title "Etoposide and Cisplatin Chemotherapy for Metastatic Good-Risk Germ Cell Tumors" @default.
- W2113289951 cites W140750605 @default.
- W2113289951 cites W1776213361 @default.
- W2113289951 cites W1849826284 @default.
- W2113289951 cites W1866644500 @default.
- W2113289951 cites W1874463527 @default.
- W2113289951 cites W1874791016 @default.
- W2113289951 cites W1970666579 @default.
- W2113289951 cites W2083927272 @default.
- W2113289951 cites W2146023815 @default.
- W2113289951 cites W2175965103 @default.
- W2113289951 cites W4293241248 @default.
- W2113289951 cites W44254208 @default.
- W2113289951 doi "https://doi.org/10.1200/jco.2005.03.6616" @default.
- W2113289951 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16361627" @default.
- W2113289951 hasPublicationYear "2005" @default.
- W2113289951 type Work @default.
- W2113289951 sameAs 2113289951 @default.
- W2113289951 citedByCount "87" @default.
- W2113289951 countsByYear W21132899512012 @default.
- W2113289951 countsByYear W21132899512013 @default.
- W2113289951 countsByYear W21132899512014 @default.
- W2113289951 countsByYear W21132899512015 @default.
- W2113289951 countsByYear W21132899512016 @default.
- W2113289951 countsByYear W21132899512017 @default.
- W2113289951 countsByYear W21132899512018 @default.
- W2113289951 countsByYear W21132899512019 @default.
- W2113289951 countsByYear W21132899512020 @default.
- W2113289951 countsByYear W21132899512021 @default.
- W2113289951 countsByYear W21132899512022 @default.
- W2113289951 crossrefType "journal-article" @default.
- W2113289951 hasAuthorship W2113289951A5005184400 @default.
- W2113289951 hasAuthorship W2113289951A5008235255 @default.
- W2113289951 hasAuthorship W2113289951A5021164812 @default.
- W2113289951 hasAuthorship W2113289951A5022528773 @default.
- W2113289951 hasAuthorship W2113289951A5054077386 @default.
- W2113289951 hasAuthorship W2113289951A5059063118 @default.
- W2113289951 hasAuthorship W2113289951A5064884168 @default.
- W2113289951 hasBestOaLocation W21132899511 @default.
- W2113289951 hasConcept C126322002 @default.
- W2113289951 hasConcept C141071460 @default.
- W2113289951 hasConcept C143998085 @default.
- W2113289951 hasConcept C2776232574 @default.
- W2113289951 hasConcept C2776694085 @default.
- W2113289951 hasConcept C2776938808 @default.
- W2113289951 hasConcept C2778119113 @default.
- W2113289951 hasConcept C2778239845 @default.
- W2113289951 hasConcept C2781413609 @default.
- W2113289951 hasConcept C71924100 @default.
- W2113289951 hasConceptScore W2113289951C126322002 @default.
- W2113289951 hasConceptScore W2113289951C141071460 @default.
- W2113289951 hasConceptScore W2113289951C143998085 @default.
- W2113289951 hasConceptScore W2113289951C2776232574 @default.
- W2113289951 hasConceptScore W2113289951C2776694085 @default.
- W2113289951 hasConceptScore W2113289951C2776938808 @default.
- W2113289951 hasConceptScore W2113289951C2778119113 @default.
- W2113289951 hasConceptScore W2113289951C2778239845 @default.
- W2113289951 hasConceptScore W2113289951C2781413609 @default.
- W2113289951 hasConceptScore W2113289951C71924100 @default.
- W2113289951 hasIssue "36" @default.
- W2113289951 hasLocation W21132899511 @default.
- W2113289951 hasLocation W21132899512 @default.
- W2113289951 hasOpenAccess W2113289951 @default.
- W2113289951 hasPrimaryLocation W21132899511 @default.
- W2113289951 hasRelatedWork W2062060133 @default.
- W2113289951 hasRelatedWork W2072122943 @default.
- W2113289951 hasRelatedWork W2077980843 @default.
- W2113289951 hasRelatedWork W2105229494 @default.
- W2113289951 hasRelatedWork W2418486715 @default.
- W2113289951 hasRelatedWork W2424108965 @default.
- W2113289951 hasRelatedWork W2435262437 @default.
- W2113289951 hasRelatedWork W2516045380 @default.
- W2113289951 hasRelatedWork W4241272416 @default.
- W2113289951 hasRelatedWork W4385538032 @default.
- W2113289951 hasVolume "23" @default.
- W2113289951 isParatext "false" @default.
- W2113289951 isRetracted "false" @default.
- W2113289951 magId "2113289951" @default.
- W2113289951 workType "article" @default.